Aurobindo Pharma Limited (APL), one of the worlds top ... In the year 1998, the company had launched new formulations like auronim Suspension in the paediatric segment. During 1999-2000, the ...

Aurobindo Pharma Ltd (BOM:524804) reports robust financial performance with significant growth in European and specialty segments, despite challenges in key markets.

Aurobindo Pharma's stock experienced a price fall during today's trading session. The stock is currently trading at Rs 1,167.10, reflecting a decrease of 2.02%. This movement places Aurobindo ...

Generic drugmaker Aurobindo Pharma, through wholly owned subsidiary Apitoria on Friday, announced the launch of a six-month post-graduation certification in leadership (CLP) programme at the ...

Aurobindo Pharma, through its wholly owned subsidiary Apitoria, launched ‘Auro Astra’ a leadership development initiative in collaboration with the Institute of Management Technology ...

During today's trading session, Aurobindo Pharma shares experienced a decline of 2.01%, with the current price at Rs 1141.50. This movement positions Aurobindo Pharma among the top losers within ...

Aurobindo Pharma subsidiary CuraTeQ Biologics s.r.o. has received marketing authorisation for Zefylti, its filgrastim biosimilar version, from Medicines and Healthcare products Regulatory Agency ...

GIC, Vadilal Industries, Aurobindo Pharma, Sumimoto Chemical, Nazara Technologies, and Blue Dart are among 205 companies to ...

Key pharma stocks, including Granules India and Gland Pharma, have shown substantial recovery, with the Nifty Pharma index ...

Aurobindo Pharma (ARBP) is actively investing across multiple high-potential segments to drive sustained growth over the next 3-5 years. The company’s Penicillin G (PEN-G) project is scaling up ...

Shares rose over 3% following brokerage upgrade Motilal Oswal changed rating to Buy with ₹1,360 target Stock down 25% from recent high of ₹1,592 Shares of Aurobindo Pharma rose over 3% on ...